Lynch syndrome. What is Lynch syndrome? How common is Lynch syndrome? What genes are related to Lynch syndrome?

Size: px
Start display at page:

Download "Lynch syndrome. What is Lynch syndrome? How common is Lynch syndrome? What genes are related to Lynch syndrome?"

Transcription

1 1 of :57 AM What is Lynch syndrome? Lynch syndrome A service of the U.S. National Library of Medicine Reviewed May 2013 Lynch syndrome, often called hereditary nonpolyposis colorectal cancer (HNPCC), is an inherited disorder that increases the risk of many types of cancer, particularly cancers of the colon (large intestine) and rectum, which are collectively referred to as colorectal cancer. People with Lynch syndrome also have an increased risk of cancers of the stomach, small intestine, liver, gallbladder ducts, upper urinary tract, brain, and skin. Additionally, women with this disorder have a high risk of cancer of the ovaries and lining of the uterus (the endometrium). People with Lynch syndrome may occasionally have noncancerous (benign) growths (polyps) in the colon, called colon polyps. In individuals with this disorder, colon polyps occur earlier but not in greater numbers than they do in the general population. How common is Lynch syndrome? In the United States, about 140,000 new cases of colorectal cancer are diagnosed each year. Approximately 3 to 5 percent of these cancers are caused by Lynch syndrome. What genes are related to Lynch syndrome? Variations in the MLH1, MSH2, MSH6, PMS2, or EPCAM gene increase the risk of developing Lynch syndrome. The MLH1, MSH2, MSH6, and PMS2 genes are involved in the repair of mistakes that occur when DNA is copied in preparation for cell division (a process called DNA replication). Mutations in any of these genes prevent the proper repair of DNA replication mistakes. As the abnormal cells continue to divide, the accumulated mistakes can lead to uncontrolled cell growth and possibly cancer. Mutations in the EPCAM gene also lead to impaired DNA repair, although the gene is not itself involved in this process. The EPCAM gene lies next to the MSH2 gene on chromosome 2; certain EPCAM gene mutations cause the MSH2 gene to be turned off (inactivated), interrupting DNA repair and leading to accumulated DNA mistakes. Although mutations in these genes predispose individuals to cancer, not all people who carry these mutations develop cancerous tumors. Related Gene(s) Changes in these genes are associated with Lynch syndrome. EPCAM MLH1 MSH2 MSH6 PMS2

2 2 of :57 AM How do people inherit Lynch syndrome? Lynch syndrome cancer risk is inherited in an autosomal dominant pattern, which means one inherited copy of the altered gene in each cell is sufficient to increase cancer risk. It is important to note that people inherit an increased risk of cancer, not the disease itself. Not all people who inherit mutations in these genes will develop cancer. Where can I find information about diagnosis or management of Lynch syndrome? These resources address the diagnosis or management of Lynch syndrome and may include treatment providers. American Medical Association and National Coalition for Health Professional Education in Genetics: Understand the Basics of Genetic Testing for Hereditary Colorectal Cancer ( GeneFacts: Lynch Syndrome: Management ( content&view=article&id=492:management&catid=113:lynch-syndrome&itemid=665) Gene Review: Lynch Syndrome ( Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 3 ( Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 4 ( Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 5 ( Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 8 ( Genetic Testing Registry: Lynch syndrome ( C ) Genetic Testing Registry: Lynch syndrome I ( C ) Genetic Testing Registry: Lynch syndrome II ( C ) MedlinePlus Encyclopedia: Colon Cancer ( htm) National Cancer Institute: Genetic Testing for Hereditary Cancer Syndromes ( You might also find information on the diagnosis or management of Lynch syndrome in Educational resources ( and Patient support ( General information about the diagnosis ( and management ( of genetic conditions is available in the Handbook. Read more about genetic testing ( particularly the difference between clinical tests and research tests ( researchtesting).

3 3 of :57 AM To locate a healthcare provider, see How can I find a genetics professional in my area? ( in the Handbook. Where can I find additional information about Lynch syndrome? You may find the following resources about Lynch syndrome helpful. These materials are written for the general public. MedlinePlus - Health information Encyclopedia: Colon Cancer ( htm) Health Topic: Cancer--Living with Cancer ( cancerlivingwithcancer.html) Health Topic: Colorectal Cancer ( colorectalcancer.html) Genetic and Rare Diseases Information Center - Information about genetic conditions and rare diseases ( Additional NIH Resources - National Institutes of Health National Cancer Institute: Colon and Rectal Cancer ( types/colon-and-rectal) National Cancer Institute: Genetics of Colorectal Cancer ( cancertopics/pdq/genetics/colorectal/healthprofessional/page2) National Human Genome Research Institute: Learning About Colon Cancer ( NIH Senior Health: Colorectal Cancer ( colorectalcancerdefined/01.html) Educational resources - Information pages American Cancer Society: Colon and Rectum Cancer ( colonandrectumcancer/detailedguide/index) CDC: Colorectal (Colon) Cancer ( Cleveland Clinic ( hnpcc.aspx) Disease InfoSearch: Hereditary Non-Polyposis Colorectal Cancer (HNPCC) ( HNPCC%29/3371) Genetic Science Learning Center, University of Utah ( content/disorders/whataregd/colon/index.html) Mayo Clinic ( My46 Trait Profile ( type=profile)

4 4 of :57 AM Orphanet ( Stanford Cancer Center ( hpncc.html) Patient support - For patients and families Colon Cancer Alliance ( Colon Cancer Alliance for Research and Education for Lynch Syndrome ( Colorectal Cancer Coalition ( Lynch Syndrome International ( You may also be interested in these resources, which are designed for healthcare professionals and researchers. Gene Reviews - Clinical summary ( Genetic Testing Registry - Repository of genetic test information Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 3 ( Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 4 ( Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 5 ( Genetic Testing Registry: Hereditary nonpolyposis colorectal cancer type 8 ( Genetic Testing Registry: Lynch syndrome ( C ) Genetic Testing Registry: Lynch syndrome I ( C ) Genetic Testing Registry: Lynch syndrome II ( C ) ClinicalTrials.gov - Linking patients to medical research ( cond=%22hereditary%20nonpolyposis%20colorectal%20cancer%22%20or%20%22 colorectal%20neoplasms%2c%20hereditary%20nonpolyposis%22) PubMed - Recent literature ( syndrome%5btiab%5d)%20and%20english%5bla%5d%20and%20human%5bmh%5d %20AND%20%22last%20360%20days%22%5Bdp%5D) OMIM - Genetic disorder catalog COLORECTAL CANCER ( LYNCH SYNDROME I (

5 5 of :57 AM What other names do people use for Lynch syndrome? cancer family syndrome familial nonpolyposis colon cancer hereditary nonpolyposis colorectal cancer hereditary nonpolyposis colorectal neoplasms HNPCC For more information about naming genetic conditions, see the Genetics Home Reference Condition Naming Guidelines ( and How are genetic conditions and genes named? ( in the Handbook. What if I still have specific questions about Lynch syndrome? Ask the Genetic and Rare Diseases Information Center ( What glossary definitions help with understanding Lynch syndrome? autosomal ; autosomal dominant ; benign ; cancer ; cell ; cell division ; chromosome ; colon ; colorectal ; DNA ; DNA repair ; DNA replication ; endometrium ; familial ; gallbladder ; gene ; intestine ; neoplasms ; population ; rectum ; stomach ; syndrome You may find definitions for these and many other terms in the Genetics Home Reference Glossary ( References Annie Yu HJ, Lin KM, Ota DM, Lynch HT. Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev Dec;29(6): Review. ( pubmed/ ?dopt=abstract) Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer. 2005;4(4): Review. ( Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med Apr 1;138(7): Review. ( pubmed/ ?dopt=abstract) Gene Review: Lynch Syndrome ( Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med May 5;352(18): ( Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, Goossens M, Haufe A, Kamping E, Niessen RC, Hogervorst FB, Gille JJ, Redeker B, Tops CM, van Gijn ME, van den Ouweland AM, Rahner N, Steinke V, Kahl P, Holinski-Feder E, Morak M, Kloor M, Stemmler S, Betz B, Hutter P, Bunyan DJ, Syngal S, Culver JO, Graham T, Chan TL, Nagtegaal ID, van Krieken JH, Schackert HK, Hoogerbrugge N, van Kessel AG, Ligtenberg MJ. Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat Apr;32(4): doi: /humu Epub 2011 Mar 1. (

6 6 of :57 AM Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, Papadopoulos N, Kinzler KW, Vogelstein B, Peltomäki P, Kolodner RD, Nilbert M, Lindblom A. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst Feb 21;99(4): ( Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet Jan;41(1): doi: /ng.283. Epub 2008 Dec 21. ( pubmed/ ?dopt=abstract) Lucci-Cordisco E, Zito I, Gensini F, Genuardi M. Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A Nov 1;122A(4): Review. ( Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med Mar 6;348(10): Review. ( Lynch HT, Lynch JF. What the physician needs to know about Lynch syndrome: an update. Oncology (Williston Park) Apr;19(4):455-63; discussion 463-4, 466, 469. Review. ( Martín-López JV, Fishel R. The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome. Fam Cancer Jun;12(2): doi: /s x. ( Peltomäki P. Lynch syndrome genes. Fam Cancer. 2005;4(3): Review. ( Rahner N, Steinke V, Schlegelberger B, Eisinger F, Hutter P, Olschwang S. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update Eur J Hum Genet Jan;21(1). doi: /ejhg Epub 2012 Aug 15. ( pubmed/ ?dopt=abstract) Rowley PT. Inherited susceptibility to colorectal cancer. Annu Rev Med. 2005;56: Review. ( Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst Feb 18;96(4): ( pubmed/ ?dopt=abstract) The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? ( handbook/consult/findingprofessional) in the Handbook. Reviewed: May 2013 Published: November 4, 2013

7 7 of :57 AM Lister Hill National Center for Biomedical Communications U.S. National Library of Medicine, National Institutes of Health Department of Health & Human Services, USA.gov Freedom of Information Act Copyright Privacy Accessibility Indicates a page outside Genetics Home Reference. Links to web sites outside the Federal Government do not constitute an endorsement. For selection criteria for web links, see Genetics Home Reference at

A Review from the Genetic Counselor s Perspective

A Review from the Genetic Counselor s Perspective : A Review from the Genetic Counselor s Perspective Erin Sutcliffe, MS, CGC Certified Genetic Counselor Cancer Risk Evaluation Program INTRODUCTION Errors in base pair matching that occur during DNA replication,

More information

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals. The gene is a tumor suppressor gene. Tumor suppressor genes slow down cell division, repair DNA mistakes, or tell cells when to die. When they don't work properly, cells can grow out of control, which

More information

MRC-Holland MLPA. Description version 29;

MRC-Holland MLPA. Description version 29; SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,

More information

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS

More information

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual 2.04.08 Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Last Review: December 2016 Effective Date: January 15, 2017 Related Policies: 2.04.53 KRAS,

More information

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome

GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual

More information

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome

Lynch Syndrome. A Patient s Guide to Genetic Testing for Lynch Syndrome Lynch Syndrome A Patient s Guide to Genetic Testing for Lynch Syndrome What is Lynch Syndrome? Lynch syndrome is an inherited condition that increases your risk of developing colon cancer and other cancers

More information

Medical Benefit Effective Date: 04/01/12 Next Review Date: 01/13 Preauthorization* Yes Review Dates: 01/10, 01/11, 01/12

Medical Benefit Effective Date: 04/01/12 Next Review Date: 01/13 Preauthorization* Yes Review Dates: 01/10, 01/11, 01/12 Genetic Testing for Inherited Susceptibility to Colon Cancer, (20408) Medical Benefit Effective Date: 04/01/12 Next Review Date: 01/13 Preauthorization* Yes Review Dates: 01/10, 01/11, 01/12 The following

More information

The Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto

The Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto Immunohistochemical Assessment of Mismatch Repair Proteins in Endometrial Cancer: The Whys and How Terence J. Colgan, MD Head of Gynaecological Pathology, Mount Sinai Hospital, University of Toronto, Toronto.

More information

Lynch Syndrome. Angie Strang, PGY2

Lynch Syndrome. Angie Strang, PGY2 Lynch Syndrome Angie Strang, PGY2 Background Previously hereditary nonpolyposis colorectal cancer Autosomal dominant inherited cancer susceptibility syndrome Caused by defects in the mismatch repair system

More information

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary

More information

MSH6 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MSH6 Summary Cancer Risk Table

MSH6 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MSH6 Summary Cancer Risk Table MSH6 gene Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MSH6 Summary Cancer Risk Table CANCER Colorectal GENETIC CANCER RISK High Risk Endometrial High Risk

More information

Germline deletions in the EPCAM gene as a cause of Lynch syndrome literature review

Germline deletions in the EPCAM gene as a cause of Lynch syndrome literature review Tutlewska et al. Hereditary Cancer in Clinical Practice 2013, 11:9 REVIEW Open Access Germline deletions in the EPCAM gene as a cause of Lynch syndrome literature review Katarzyna Tutlewska *, Jan Lubinski

More information

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer? Important points The most important factors that can influence an individual s chance of developing bowel cancer are getting older and having a family history of bowel cancer A family history of bowel

More information

LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!

LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)! LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)! Kathryn Singh, MPH, MS, LCGC Associate Clinical Professor Assistant Director, Graduate Program in Genetic Counseling Division of Genetic and Genomic

More information

Measure Description. Denominator Statement

Measure Description. Denominator Statement CMS ID/CMS QCDR ID: CAP 18 Title: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic

More information

The Next Generation of Hereditary Cancer Testing

The Next Generation of Hereditary Cancer Testing The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,

More information

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer A Patient s Guide to risk assessment Hereditary Colorectal Cancer Hereditary Cancer Testing: Is it Right for You? Overview of Syndromes This workbook is designed to help you decide if hereditary cancer

More information

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer Integrated Cancer Research Group, Lowy Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia Correspondence to: Dr M P Hitchins, UNSW Cancer Research

More information

MLH1 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MLH1 Summary Cancer Risk Table

MLH1 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) MLH1 Summary Cancer Risk Table MLH1 gene Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Cancer (HNPCC) MLH1 Summary Cancer Risk Table CANCER GENETIC CANCER RISK Endometrial Other MLH1 gene Overview Lynch syndrome 1,

More information

Page 1 of 8 TABLE OF CONTENTS

Page 1 of 8 TABLE OF CONTENTS Page 1 of 8 TABLE OF CONTENTS Patient Evaluation and Recommendation..Page 2 Testing and Follow-up..Page 3 Genetic Counseling Referral Criteria.....Page 4-5 Patient Education..Page 6 Suggested Readings...Page

More information

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary

More information

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial

More information

Turcot Syndrome with Gliosarcoma: A rare variation of a Lynch Syndrome Phenotype

Turcot Syndrome with Gliosarcoma: A rare variation of a Lynch Syndrome Phenotype ARC Journal of Clinical Case Reports Volume 3, Issue 3, 2017, PP 9-14 ISSN No. (Online) 2455-9806 DOI: http://dx.doi.org/10.20431/2455-9806.0303003 www.arcjournals.org Turcot Syndrome with Gliosarcoma:

More information

Comprehensive Molecular Analysis of Mismatch Repair Gene Defects in Suspected Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Cases

Comprehensive Molecular Analysis of Mismatch Repair Gene Defects in Suspected Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Cases Comprehensive Molecular Analysis of Mismatch Repair Gene Defects in Suspected Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Cases James Mueller, 1 Isabella Gazzoli, 1 Prathap Bandipalliam,

More information

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk What a history of cancer may mean for you and your family and the steps you can take to reduce the risk www.myriadtests.com 1-800-469-7423 Family Ties and Colon Cancer In every family, certain traits are

More information

Practice Gaps: Essential Genetics

Practice Gaps: Essential Genetics FRM F017 Practice Gaps: Essential Genetics Jennifer L. Hand MD Associate Professor of Dermatology, Clinical Genomics, and Pediatrics Section Head, Dermatology Genetics Mayo Clinic, Rochester, MN, USA DISCLOSURE

More information

Fourfold increased detection of Lynch syndrome by raising age limit for. tumour genetic testing from 50 to 70 years is cost-effective

Fourfold increased detection of Lynch syndrome by raising age limit for. tumour genetic testing from 50 to 70 years is cost-effective Annals of Oncology Advance Access published July 31, 2014 1 Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective A.S. Sie

More information

Hereditary Colorectal Cancer

Hereditary Colorectal Cancer A Patient s Guide to risk assessment Hereditary Colorectal Cancer Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer testing is right for

More information

Colorectal cancer susceptibility associated with the hmlh1 V384D variant

Colorectal cancer susceptibility associated with the hmlh1 V384D variant Molecular Medicine REPORTS 2: 887-891, 2009 Colorectal cancer susceptibility associated with the hmlh1 V384D variant TOMONORI OHSAWA 1,4, TOMOKO SAHARA 1,5, SHINO MURAMATSU 1,5, YOJI NISHIMURA 2, TOSHIMASA

More information

PMS2 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) PMS2 Summary Cancer Risk Table

PMS2 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) PMS2 Summary Cancer Risk Table PMS2 gene Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) PMS2 Summary Cancer Risk Table CANCER Colorectal GENETIC CANCER RISK High Risk Endometrial High Risk

More information

A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-italy

A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-italy DOI 10.1007/s10689-006-9110-z ORIGINAL PAPER A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-italy Francesca Bianchi Æ Eva Galizia Æ Emilio Porfiri Æ Laura Belvederesi

More information

Understanding and Managing Lynch Syndrome

Understanding and Managing Lynch Syndrome Understanding and Managing Lynch Syndrome Princess Margaret For women who may have Lynch syndrome and their family members Please visit the UHN Patient Education website for more health information: www.uhnpatienteducation.ca

More information

Clinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability

Clinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability The Korean Journal of Pathology 29; 43: 428-34 DOI: 1.4132/KoreanJPathol.29.43.5.428 Clinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability Sang Kyum Kim Junjeong

More information

Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion

Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion (2006) 14, 63 68 & 2006 Nature Publishing Group All rights reserved 1018-4813/06 $30.00 www.nature.com/ejhg ARTICLE Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICAL POLICY Genetic Testing for Colorectal Cancer Susceptibility MP-018-MD-DE Provider Notice Date: 11/1/2016 Original Effective Date: 12/1/2016 Annual

More information

Biology of Cancer Writing Assignment

Biology of Cancer Writing Assignment 1 Biology of Cancer Writing Assignment Based on the information below, you will write a research proposal 3- pages in length (double-spaced, not including references). Draw upon information that you have

More information

Hereditary Cancer Syndromes

Hereditary Cancer Syndromes Hereditary Cancer Syndromes Nicoleta Voian, MD, MPH Director Clinical Genetics Service Roswell Park Cancer Institute Nicoleta.Voian@Roswellpark.org February 28, 2017 Common Genetics Terms Gene: A hereditary

More information

Asingle inherited mutant gene may be enough to

Asingle inherited mutant gene may be enough to 396 Cancer Inheritance STEVEN A. FRANK Asingle inherited mutant gene may be enough to cause a very high cancer risk. Single-mutation cases have provided much insight into the genetic basis of carcinogenesis,

More information

Pathology perspective of colonic polyposis syndromes

Pathology perspective of colonic polyposis syndromes Pathology perspective of colonic polyposis syndromes When are too many polyps too many? David Schaeffer Head and Consultant Pathologist, Department of Pathology and Laboratory Medicine, Vancouver General

More information

Subject: Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Subject: Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes 05-82000-31 Original Effective Date: 10/15/01 Reviewed: 10/25/18 Revised: 11/15/18 Subject: Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes THIS MEDICAL COVERAGE GUIDELINE

More information

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014 Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October

More information

PENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II)

PENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II) Stage I: Binning Dashboard GENE/GENE PANEL: APC ACTIONABILITY 1. Is there a qualifying resource, such as a practice guideline or systematic review, for the genetic condition? 2. Does the practice guideline

More information

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer s on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer Francis M. Giardiello, MD, 1 John I. Allen, 2 Jennifer E. Axilbund,

More information

Protocols 5-8. Background information for Lynch Syndrome evaluation and investigation

Protocols 5-8. Background information for Lynch Syndrome evaluation and investigation Protocols 5-8 Background information for Lynch Syndrome evaluation and investigation Dated: 01/11/13 Reviewed 18/11/14 Q: What is the sensitivity of IHC? Overall IHC is 95-100% sensitive (Shia, 2008, Caldes

More information

Information for You and Your Family

Information for You and Your Family Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the

More information

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University 1. I am a surgeon; of course I have nothing to disclose.

More information

Clinicopathological Features and Type of Surgery for Lynch Syndrome: Changes during the Past Two Decades

Clinicopathological Features and Type of Surgery for Lynch Syndrome: Changes during the Past Two Decades pissn 1598-2998, eissn 2005-9256 Cancer Res Treat. 2016;48(2):605-611 Original Article http://dx.doi.org/10.4143/crt.2015.092 Open Access Clinicopathological Features and Type of Surgery for Lynch Syndrome:

More information

Primary Care Approach to Genetic Cancer Syndromes

Primary Care Approach to Genetic Cancer Syndromes Primary Care Approach to Genetic Cancer Syndromes Jason M. Goldman, MD, FACP FAU School of Medicine Syndromes Hereditary Breast and Ovarian Cancer (HBOC) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)

More information

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome

Content. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines

More information

Development of Carcinoma Pathways

Development of Carcinoma Pathways The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019

More information

What All of Us Should Know About Cancer and Genetics

What All of Us Should Know About Cancer and Genetics What All of Us Should Know About Cancer and Genetics Beth A. Pletcher, MD, FAAP, FACMG Associate Professor of Pediatrics UMDNJ- New Jersey Medical School Disclosures I have no relevant financial relationships

More information

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696 Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Genetic Testing for Colorectal Cancer Susceptibility MP-018-MD-DE Medical Management Provider Notice Date: 10/01/2017 Original

More information

T he lifetime risk of developing colorectal cancer is 5%, with. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer CANCER

T he lifetime risk of developing colorectal cancer is 5%, with. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer CANCER 228 CANCER Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer G Lindgren, A Liljegren, E Jaramillo, C Rubio, A Lindblom... See end of article for authors affiliations... Correspondence

More information

Caring for Patients at Risk for Hereditary Colorectal Cancer

Caring for Patients at Risk for Hereditary Colorectal Cancer February 05, 2007 By Karen Greco, PhD, RN, ANP [1] About 6% of colorectal cancers are caused by genetic mutations associated with hereditary colorectal cancer syndromes. The most common hereditary cancer

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer

Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer 1311 Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer Christina Rybak, MS, CGC, and Michael J. Hall, MD, MS, Philadelphia, Pennsylvania Key Words

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY CLINICAL MEDICAL POLICY Policy Name: Genetic Testing for Colorectal Cancer Susceptibility Policy Number: MP-018-MD-WV Responsible Department(s): Medical Management Provider Notice Date: 10/01/2017; 11/01/2016

More information

Colorectal carcinoma (CRC) was traditionally thought of

Colorectal carcinoma (CRC) was traditionally thought of Testing for Defective DNA Mismatch Repair in Colorectal Carcinoma A Practical Guide Lawrence J. Burgart, MD Context. Significant bench and clinical data have been generated during the last decade regarding

More information

Mismatch Repair Deficiency Tumour Testing for Patients with Colorectal Cancer: Recommendations

Mismatch Repair Deficiency Tumour Testing for Patients with Colorectal Cancer: Recommendations CADTH Optimal Use Report Mismatch Repair Deficiency Tumour Testing for Patients with Colorectal Cancer: Recommendations Draft Recommendations Report April 2016 Cite as: Canadian Agency for Drugs and Technologies

More information

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry FAMILIAL COLORECTAL CANCER Lyn Schofield Manager Familial Cancer Registry Cancer in WA 2004 4000 3500 ASPR, rate per 100,000 3000 2500 2000 1500 1000 Male incidence Female incidence Male mortality Female

More information

Incidence and Clinical Characteristics of Colonic and Extra Colonic Lynch Syndrome Manifestations in Uruguayan Mismatch Repair Carriers

Incidence and Clinical Characteristics of Colonic and Extra Colonic Lynch Syndrome Manifestations in Uruguayan Mismatch Repair Carriers Research Article imedpub Journals http://www.imedpub.com/ Colorectal Cancer: Open Access ISSN 47-9943 07 Vol.3 No.:6 DOI: 0.767/47-9943.00036 Incidence and Clinical Characteristics of Colonic and Extra

More information

Result Navigator Positive Test Result: MSH6

Result Navigator Positive Test Result: MSH6 Result Navigator Positive Test Result: MSH6 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases

Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases ASIP 2011 JMD CME Program The Journal of Molecular Diagnostics, Vol. 13, No. 1, January 2011 Copyright 2011 American Society for Investigative Pathology and the Association for Molecular Pathology. Published

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

Update on Hereditary Colorectal Cancer

Update on Hereditary Colorectal Cancer doi:10.21873/anticanres.10983 Review Update on Hereditary Colorectal Cancer FELIPE CARNEIRO DA SILVA 1, PATRIK WERNHOFF 2, CONSTANTINO DOMINGUEZ-BARRERA 3 and MEV DOMINGUEZ-VALENTIN 4 1 Laboratory of Experimental

More information

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change

More information

Molecular aspects of HNPCC and identification of mutation carriers Niessen, Renee

Molecular aspects of HNPCC and identification of mutation carriers Niessen, Renee University of Groningen Molecular aspects of HNPCC and identification of mutation carriers Niessen, Renee IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

case report Reprinted from August 2013

case report Reprinted from August 2013 Reprinted from August 2013 A 48-year-old woman with endometrial cancer Importance of screening for Lynch syndrome in patients with EC CAP TODAY and the Association for Molecular Pathology have teamed up

More information

The molecular genetics of colorectal cancer

The molecular genetics of colorectal cancer 1 Department of Gastroenterology, North Middlesex University Hospital, London, UK 2 Institute of Molecular Genetics, Cardiff University 3 Department of Gastroenterology, Queen s Hospital Romford, London,

More information

Deletions Account for 17% of Pathogenic Germline Alterations in MLH1 and MSH2 in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Families ABSTRACT

Deletions Account for 17% of Pathogenic Germline Alterations in MLH1 and MSH2 in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Families ABSTRACT GENETIC TESTING Volume 9, Number 2, 2005 Mary Ann Liebert, Inc. Deletions Account for 17% of Pathogenic Germline Alterations in MLH1 and MSH2 in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Families

More information

Hereditary nonpolyposis colorectal cancer and familial colorectal cancer. in Central part of Iran, Isfahan

Hereditary nonpolyposis colorectal cancer and familial colorectal cancer. in Central part of Iran, Isfahan Received: 30.1.2011 Accepted: 6.1.2012 Original Article Hereditary nonpolyposis colorectal cancer and familial colorectal cancer in Central part of Iran, Isfahan Amin Nemati 1, Zahra Kazemi Rahmatabadi

More information

Management of higher risk of colorectal cancer. Huw Thomas

Management of higher risk of colorectal cancer. Huw Thomas Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)

More information

Universal Screening for Lynch Syndrome

Universal Screening for Lynch Syndrome Universal Screening for Lynch Syndrome St. Vincent/Ameripath protocol proposal Lynch syndrome (HNPCC) 1/35 individuals with colorectal cancer has Lynch syndrome Over half individuals are >50 at time of

More information

journal of medicine The new england Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) abstract

journal of medicine The new england Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) abstract The new england journal of medicine established in 1812 may 5, 2005 vol. 352 no. 18 Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Heather Hampel, M.S., Wendy L. Frankel,

More information

Célia DeLozier-Blanchet

Célia DeLozier-Blanchet The Genetics Consultation in OB-GYN : Hereditary cancers Célia DeLozier-Blanchet Division of Medical Genetics, Geneva University Hospital It is probable that all cancers are genetic! genetic vs. hereditary

More information

Colon Cancer and Hereditary Cancer Syndromes

Colon Cancer and Hereditary Cancer Syndromes Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models

More information

New Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba

New Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba New Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba If you are looking for a book by Shozo Baba New Strategy for Treatment of Hereditary Colorectal Cancer in pdf form, then you have

More information

CLINICAL FOCUS. Juvenile Polyposis. Winter 2009

CLINICAL FOCUS. Juvenile Polyposis. Winter 2009 CLINICAL FOCUS Juvenile Polyposis Carol Durno, MD, MSc Registry Pediatric Gastroenterologist People can have many polyps in the gastrointestinal tract. The type and number of polyps found help determine

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our

More information

Case Study. Overview. Deleterious MLH1 mutation detected on sequencing 10/16/2014

Case Study. Overview. Deleterious MLH1 mutation detected on sequencing 10/16/2014 The Role of Next Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Endometrial Cancer Laura J. Tafe, MD Assistant Professor of Pathology Assistant Director, Molecular Pathology Dartmouth-Hitchcock

More information

Serrated Polyps and a Classification of Colorectal Cancer

Serrated Polyps and a Classification of Colorectal Cancer Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram

More information

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics From clinic to genetics Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Autosomal dominant Question 2) Incidence of

More information

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER. POLICY NUMBER: CATEGORY: Laboratory Test

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER. POLICY NUMBER: CATEGORY: Laboratory Test MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER POLICY NUMBER: 2.02.11 CATEGORY: Laboratory Test EFFECTIVE DATE: 09/16/99 REVISED DATE: 04/19/01, 05/16/02, 06/19/03,

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual FEP 2.04.08 Genetic Testing for Lynch Syndrome and Other Inherited Effective Date: January 15, 2018 Related Policies: 2.0.53 KRAS, NRAS, and BRAF Variant Analysis in Metastatic

More information

National Medical Policy

National Medical Policy National Medical Policy Subject: Policy Number: Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC) (Lynch Syndrome) NMP137 Effective Date*: April 2004 Updated: March 2017 This National

More information

A636P testing in Ashkenazi Jews

A636P testing in Ashkenazi Jews Familial Cancer 3: 223 227, 2004. Ó 2004 Kluwer Academic Publishers. Printed in the Netherlands. A636P testing in Ashkenazi Jews Jose G. Guillem 1, Harvey G. Moore 1, Crystal Palmer 2, Emily Glogowski

More information

Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report

Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report Utsumi et al. World Journal of Surgical Oncology (2017) 15:140 DOI 10.1186/s12957-017-1207-3 CASE REPORT Open Access Metachronous colorectal carcinoma with massive submucosal invasion detected by annual

More information

Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia

Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia Original Article Obstet Gynecol Sci 2015;58(2):106-111 http://dx.doi.org/10.5468/ogs.2015.58.2.106 pissn 2287-8572 eissn 2287-8580 Clinical significance of mismatch repair genes immunohistochemical expression

More information

Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: a nationwide epidemiological study from Sweden

Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: a nationwide epidemiological study from Sweden doi: 10.1054/ bjoc.2001.1718, available online at http://www.idealibrary.com on http://www.bjcancer.com Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: a nationwide epidemiological

More information

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit

More information

Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma

Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma 1146 COLON CANCER Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma C Durno, M Aronson, B Bapat, Z Cohen, S Gallinger... See end of article for

More information

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit. Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is

More information

Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers.

Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers. Assessment of Universal Mismatch repair (MMR) or Microsatellite Instability (MSI) testing in colorectal cancers. Soheila Hamidpour MD, Madhusudhana S MD. MMR deficient colorectal tumors can be present

More information

The Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families

The Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families BRIEF COMMUNICATION The Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families Christopher D. South, Heather Hampel, Ilene Comeras, Judith A. Westman, Wendy L. Frankel, Albert de la Chapelle Lynch

More information